3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
16
Carcinoma, Non-Small-Cell Lung
7
Ovarian Neoplasms
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
3
Neoplasms
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Pancreatic Intraductal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Thrombosis
1
Stage IA Uterine Sarcoma
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Solid Tumor Cancer
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Peripheral Nervous System Diseases
1
Pancreatic Cyst
1
Pain
1
Organoid
1
Neoplasms, Germ Cell and Embryonal
1
NSCLC
1
Motor Activity
1
Medulloblastoma
1
Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer
1
Interventions
salicylhydroxamic acid
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
edoxaban
1
apixaban
1
X-Rays
1
Warfarin
1
Technetium Tc 99m Sulfur Colloid
1
Saline Solution
1
Rivaroxaban
1
Radiotherapy, Conformal
1
Physical Therapy Modalities
1
Photons
1
Paclitaxel
1
Musculoskeletal Manipulations
1
Fondaparinux
1
Enoxaparin
1
Docetaxel
1
Dexmedetomidine
1
Dalteparin
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Thrombosis
×
Paclitaxel
×
Clear all
NCT04324346
2021-03-18
PICC&PAC
Swedish Red Cross University College
Phase NA
Completed
250 enrolled